国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
血容量扩充药及其临床应用
Plasma Volume Extender and its Clinical Application
  
DOI:
中文关键词:  血容量扩充药 临床应用 合理用药 人血白蛋白 不良反应 血定安 贺斯 血浆代用品
英文关键词:Plasma,Volume extender,Seroalbumine Humane,Gelofusine,Haes steril,Dextram,Hydroxyethyl starch
基金项目:
郭代红  崔巍  孟潇
[1]解放军总医院第一临床药局北京100853 [2]北京大学药学院99级实践生
摘要点击次数: 1588
全文下载次数: 118
中文摘要:
      目的:综述血容量扩充药的临床合理选药用药。方法:通过检索中英文相关文献,从有效、安全、经济三方面对血容量扩充药各主要品种进行分析。结果:从药效、不良反应和成本支出综合考虑,右旋糖酐40及706代血浆以价格优势保证较高的应用量。但有较高的不良反应发生率;血定安和贺斯的成本效果较为适中;人血白蛋白因其高昂的价格,及其血液制品的潜在危险性,并非扩充血容量的最佳选择。结论:血容量扩充药应用日益增多,需从有效、安全、经济综合考虑,合理选用。
英文摘要:
      Objective: To review the rational selection and utilization of plasma volume extender in clinical application.Method: The efficacy, safety and economy of main kinds of plasma volume extender were analyzed through indexing its English and Chinese documents concerned.Result: Dextram 40 and Hydroxyethyl starch have been maintaining their high utilization due to their dominance in price despite higher rates of ADRs; the cost effectiveness of Gelofusine and Haes steril is appropriate considering their general consulting potency, DR reports and cost expenditure; seroalbumine humane is not the optimum selection because of its expensive price and potential hazards as blood products.Conclusion: Considered to be effective, safe and economical, the plasma volume extender should be rationally administrated because of its more and more application.
查看全文  查看/发表评论  下载PDF阅读器
关闭